Home
About
Overview
Sharing Data
ORCID
Help
History (58)
Kang, Yongsung
Cole, Naida
Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia.
Short (= 1 mm) positive surgical margin and risk of biochemical recurrence after radical prostatectomy.
Oxidative reactive species in cell injury: Mechanisms in diabetes mellitus and therapeutic approaches.
See All 58 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Oxidative reactive species in cell injury: Mechanisms in diabetes mellitus and therapeutic approaches.
Oxidative reactive species in cell injury: Mechanisms in diabetes mellitus and therapeutic approaches. Ann N Y Acad Sci. 2005 Dec; 1066:136-51.
View in:
PubMed
subject areas
Animals
Antioxidants
Cells
Diabetes Complications
Diabetes Mellitus, Type 2
Humans
Insulin Resistance
Insulin-Secreting Cells
Oxidative Stress
Reactive Oxygen Species
authors with profiles
Louis Philipson